1Kost RG, Straus SE. Postherpetic neuralgia-pathogenesis treatment and prevention. New Engl Med, 1996,335:32-34
2Johnson R. Hepes zoster-predicting and minimizing the inpact of post-herpetic neuralgia. Antinicorb Chemother,2001, 47 : suppl 1 : 1-8
3Gazewood JD, Meadows S, Halverson L. Clinical inquiries: What is the prognosis of postherpetic neuralgia. Faro Pract, 2003,52:496-497
4Baranowski AP. Trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. Pain Symptom Manage, 1997,17:492-433
5Whiteley R J, Shukla S, Crooks RJ. The identification of risk factors associated with persistent pain following hepes zoster. Infect Dis, 1998,178 (Suppl) : S71-5
6Dworkin RH. The management of postherpetic neuralgia. BMJ, 2000,788-9
7Dworkin RH, Schmader KE. The epidermiology and natural history of hepes zoster and potherpetic neuralgia. In : C. P. N. Watson, A. A. Gershon, editors. Herpes zoster and potherpetic neuralgia,2nd revised and enlarged ed. New York: Elsevier Sciences ,2001, PP. 39-64
8Liesegamg TJ, Baranonski AP, et al. Management of postherpetic neuralgia. Pain, 2002,58 : 347-354
10Darsow ULF, Lorenz J, Burkhart Bromm Ring J. Pruris circumscrptus sine material: a sequel of postherpetic neuralgia. Acta Derm Venereol(stockh) , 1996,76:45-47
2Oaklander AL.Pathology of Shingles .Arch Neurol,1999,56:1292-1294.
3Pappagallo M,Oaklander AL,Quatrano-Piacentini AL,et al.Heter-ogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms.Anesthesiology,2000,92(3):691～698.
4Helgason S, Petursson G, Gudmundsson S, et al. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ,2000,321 (7264): 794-796.
5Baron R. Peripheral neuropathic pain: from mechanisms to symptoms.Clin J Pain, 2000 , 16(2 Suppl): S12-20.
6Bonezzi C, Demartini L. Treatment options in postherpetic neuralgia. Acta Neurol Scand Suppl, 1999,173: 25-35.
7Chiarello SE. Tumescent infiltration of corticosteroids, lidocaine, and epinephrine into dermatomes of acute herpetic pain or postherpetic neuralgia. Arch Dermatol, 1998 , 134(3) :279-281.
8Pappagallo M, Haldey EJ. Pharmacological management of postherpetic neuralgia. CNS Drugs, 2003,17(11) :771.
9CollinsSL, MooreRA, McQuayHJ, etal. Antidepressants and anticonvulsantsfor diabetic neuropathy and postherpetic neuralgia. J Pain Symptom Manage,2000,20(6) :449.
10Davies JL, Smith RL. Painful peripheral diabetic neuropathy treated with venlafaxine HCL extended release capsules. Diabetes Care, 1999, 22:1909.
